Navigation Links
Curemark Receives Investigational New Drug Clearance for CM-AT for Autism
Date:3/25/2009

Phase III Trial to Begin

RYE, N.Y., March 25 /PRNewswire/ -- Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application to initiate its pivotal Phase III clinical trial of CM-AT for the treatment of autism.

The company expects to begin Phase III clinical trials at multiple sites across the US in the second quarter of 2009. As part of this IND, the FDA has agreed that Curemark may proceed directly into pivotal Phase III clinical trials in patients with autism. The FDA has reviewed the quality, safety and efficacy data generated by Curemark in pediatric patients with autism. In addition, the FDA has provided written guidance on the trial protocol.

"FDA clearance of the CM-AT IND for the pivotal Phase III trial is an important milestone for Curemark," commented Dr. Joan Fallon, Curemark's CEO. "With 1 in 150 children diagnosed with autism, we have children who are suffering. We are very excited about the opportunity to enter a Phase III trial for this ever-growing population of children."

About CM-AT

As part of Curemark's ENCAPTASE(TM) technology platform, CM-AT is based upon the observation that many children with autism do not digest protein. CM-AT is a proprietary therapy formulated to be released in the small intestine of children with autism. Designed as an easily utilized powder taken three times a day, CM-AT was developed with the children in the forefront. The administration of CM-AT with meals allows for an increase in protein digestion thus potentially reducing allergy and increasing the availability of essential amino acids. With proper protein digestion in a subset of children with autism, the need for protein restricted diets, such as gluten-free and casein-free diets, to which many ch
'/>"/>

SOURCE Curemark, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford
2. Curemark Appoints Dr. Elisa J. Zinberg as Vice President of Operations
3. Curemark to Present at the 2008 Life Sciences & Healthcare Venture Summit 2008
4. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
5. DaVita Receives Civil Complaint
6. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
7. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
8. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
9. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
10. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
11. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 Guests at Napa Valley's ... indulged in a new sleep experience. The top of each ... Peacock Alley. , These expertly crafted, 100% Egyptian cotton ... from a distance, yet upon closer look, words are woven ... relax, sleep and breathe. , Intentional breathing and ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 In its ... offers treatment programs and believes that having family close ... big difference in whether or not the process is ... myths. , “It’s difficult to estimate just how damaging ... Rehabilitation’s CEO Per Wickstrom . “Not only do ...
(Date:7/29/2014)... 29, 2014 Launched in 2012 by ... surpassed 20,000 hangovers earlier this year at its Vegas ... expansion and the publication of research data related to ... practice. , The only licensed medical practice dedicated to ... launched in 2012 and treated thousands of patients within ...
(Date:7/29/2014)... 29, 2014 Ticketability.com has reduced the cost ... been selling at lower prices on the secure website. Customers ... further discount on tickets that are priced lower every day. ... tickets available at Ticketability.com. , Theatergoers know that attending an ... find Phantom of the Opera tickets for sale that are ...
(Date:7/28/2014)... July 29, 2014 Treat skin to a ... Sublime Beauty®. , Today and tomorrow only (while supplies last), ... "The cleanser is ideal for two specific users: , 1) ... unclogged and bacteria free, and , 2) aging skin to ... says Kathy Heshelow, founder of Sublime Beauty®. , Those with ...
Breaking Medicine News(10 mins):Health News:Auberge Du Soleil Offers INTENTIONS™ by Peacock Alley on Guests' Beds Providing a Unique Sleep Experience 2Health News:Latest Best Drug Rehabilitation Blog Post Busts 4 Big Addiction Myths 2Health News:Latest Best Drug Rehabilitation Blog Post Busts 4 Big Addiction Myths 3Health News:Hangover Heaven Surpasses 20,000 Hangovers 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 3Health News:Phantom of the Opera Tickets for Sale: Ticketability.com Delights Customers with Phantom of the Opera Theatre Tickets While Seats Last 2Health News:Clear, Clean Skin With the New Salicylic Wash from Sublime Beauty®; Enlivens Skin, Unclogs Pores 2
... Ten outstanding clinical research projects from institutions around the ... Research Forum Top 10 Clinical Research Achievement Awards. The ... that results from the nation,s investment in clinical research ... hail from Baylor College of Medicine, the Cleveland Clinic ...
... , WEDNESDAY, April 18 (HealthDay News) -- ... adults, risk of being hospitalized for lung and heart ... Harvard School of Public Health researchers compared air-quality data ... 65 and older admitted to 3,000 New England hospitals ...
... 17 (HealthDay News) -- Pregnant women who are overweight ... for pregnancy complications, a new study shows. These women ... normal blood sugar or those with gestational diabetes and normal ... pregnant women who are obese or have gestational diabetes, and ...
... , TUESDAY, April 17 (HealthDay News) -- A new study ... new kind of radiation treatment, in patients with prostate cancer. ... radiation therapy were more likely to suffer from gastrointestinal side ... be any extra benefit for those who got proton therapy. ...
... , TUESDAY, April 17 (HealthDay News) -- Mothers with ... according to a new study. Pennsylvania State University researchers ... the ages of 1 month and 2 years over 7 ... mothers and their infants, quality of sleep. Greater amounts ...
... HealthDay Reporter , TUESDAY, April 17 (HealthDay News) ... cells led to a nearly 50 percent improvement in survival ... that claimed the life of U.S. Sen. Edward Kennedy, a ... about 40 patients with recurrent glioblastoma -- an aggressive brain ...
Cached Medicine News:Health News:Awards celebrate clinical research that can improve health and alleviate suffering 2Health News:Awards celebrate clinical research that can improve health and alleviate suffering 3Health News:More Smog Might Mean More Hospitalizations 2Health News:Overweight Pregnant Women at Higher Risk for Complications 2Health News:Study Casts Doubt on Value of Pricey Prostate Cancer Therapy 2Health News:Study Casts Doubt on Value of Pricey Prostate Cancer Therapy 3Health News:Depressed Moms May Hinder Babies' Sleep 2Health News:Brain Tumor Vaccine Shows Promise in Early Trial 2
(Date:7/28/2014)... July 28, 2014 Reportlinker.com announces that ... its catalogue: Portugal Pharmaceuticals and ... http://www.reportlinker.com/p0207141/Portugal-Pharmaceuticals-and-Healthcare-Report-Q3-2014.html Includes 3 ... Faster-than-expected economic growth last quarter has led us ... upwards. As forecast previously, BMI expects ...
(Date:7/28/2014)... Va. , July 28, 2014  Serco ... services, announced the Company has been awarded a ... Support Command (NEMSCOM) and its Deployable Medical Systems.  ... enable medical personnel to provide world-class healthcare to ... operating environment across the globe. The five year ...
(Date:7/28/2014)... 2014  VigeneTech, Inc, in collaboration with BioLegend, ... Analysis Software, an OEM software solution for analysis ... and offers varieties of bead-based multi-analyte immunoassay products ... of VigeneTech,s data analysis software, FCS data files ... reported LEGENDplex™ software is a ...
Breaking Medicine Technology:Portugal Pharmaceuticals and Healthcare Report Q3 2014 2Portugal Pharmaceuticals and Healthcare Report Q3 2014 3Portugal Pharmaceuticals and Healthcare Report Q3 2014 4Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2
... VANCOUVER, Oct. 7 /PRNewswire-FirstCall/ - Burcon NutraScience,Corporation ... and,Supertein(TM) canola protein isolates are GRAS (Generally ... a variety of food and beverage,applications. The ... evaluation by a panel of qualified experts ...
... study of adults, VYVANSE taken once-daily significantly,improved the ... Oct. 7 Shire plc (LSE: SHP,Nasdaq: SHPGY), ... study published in the September issue of the ... Deficit Hyperactivity Disorder (ADHD) symptoms in adults within,the ...
Cached Medicine Technology:Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6
... power table has everything that you need ... new AIT-15 offers 20 mm of additional ... and locking castors to secure the table. ... for most any application. Use a double ...
If youre looking to expand your projection capabilities, without a major capital investment, consider Topcons CP-5D Chart Projector....
... all-metal Trial Frame that is durably constructed, ... design that extends the life of the ... of springs and other components. The leaf ... comfortably on the patients head. The Trial ...
Inquire...
Medicine Products: